Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Fauci: Good Zika Synergy, But Pharma No NIH Substitute

This article was originally published in Scrip

Executive Summary

While there's been some good synergy between the National Institutes of Health (NIH) and biopharmaceutical manufacturers in certain circumstances, like in the case of the current efforts to quickly develop a Zika virus vaccine, industry "will never be a substitute" for the agency, the top US government infectious disease scientist, Anthony Fauci, told lawmakers on Feb. 24.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst